C301-6105 Screening compound: 1-(5-chloro-2-methylphenyl)-4-[(4-fluorophenyl)(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]piperazine

C301-6105 Screening compound: 1-(5-chloro-2-methylphenyl)-4-[(4-fluorophenyl)(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]piperazine
C301-6105 Screening compound: 1-(5-chloro-2-methylphenyl)-4-[(4-fluorophenyl)(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound C301-6105
1-(5-chloro-2-methylphenyl)-4-[(4-fluorophenyl)(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C301-6105

Molecular Formula

C26H24ClFN4O (C26 H24 ClFN4 O)

Compound Name

1-(5-chloro-2-methylphenyl)-4-[(4-fluorophenyl)(5-phenyl-1,3,4-oxadiazol-2-yl)methyl]piperazine

IUPAC name

1-(5-chloro-2-methylphenyl)-4-[(4-fluorophenyl)(5-phenyl-134-oxadiazol-2-yl)methyl]piperazine

SMILES

Cc(ccc(Cl)c1)c1N(CC1)CCN1C(c1nnc(-c2ccccc2)o1)c(cc1)ccc1F

InChI

InChI=1S/C26H24ClFN4O/c1-18-7-10-21(27)17-23(18)31-13-15-32(16-14-31)24(19-8-11-22(28)12-9-19)26-30-29-25(33-26)20-5-3-2-4-6-20/h2-12,17,24H,13-16H2,1H3/t24-/m1/s1

InChI Key

RJHKHWUIHVCMEY-XMMPIXPASA-N

MDL Number (MFCD)

MFCD14744288

Chemical and Physical Properties

Saltdata

HCl

Molecular Weight

462.95

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

6.227

Distribution Coefficient, logD

6.227

Water Solubility, LogSw

-6.36

Polar Surface Area

36.467

Acid Dissociation Constant (pKa)

26.61

Base Dissociation Constant (pKb)

3.01

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

23.10

C301-6105 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

DGK Inhibitors Library (10558 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with C301-6105 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C301-6105?
Check Price and Availability of C301-6105, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C301-6105 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C301-6105
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C301-6105
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C301-6105 available by request